Literature DB >> 11987238

Cholelithiasis in patients with Gaucher disease.

Hanna Rosenbaum1, Ellen Sidransky.   

Abstract

Gaucher disease, the inherited deficiency of the lysosomal enzyme glucocerebrosidase, manifests with a continually expanding range of clinical features. Noting that a number of adult patients with type 1 Gaucher disease also had gallstones, we reviewed the clinical records of 66 adult patients evaluated at the National Institutes of Health with type 1 Gaucher disease. Twenty-one patients were identified who had either gallstones or a history of cholecystectomy. Of the 21 patients, 6 were male. The age at which stones were noted ranged from 19 to 70 years (mean 39 years). Thirteen of the patients had a cholecystectomy performed. Several different factors may contribute to the development of gallstones in these patients, including anemia, prior splenectomy, and hepatic involvement. Eleven of the patients were found to have chronic anemia. Fifteen of the patients underwent splenectomy. An increased biliary excretion of glucosylceramide could also contribute to cholelithiasis. To determine whether our findings were specific to our referral population, the medical records of a second series of 80 adult patients of Ashkenazi Jewish ancestry with type 1 Gaucher disease followed in Northern Israel were reviewed. Sixteen of these patients (5 male, 11 female) were also noted to have gallstones. Thus, the frequency of gallbladder involvement in patients with Gaucher disease appears to be greater than previously appreciated.

Entities:  

Mesh:

Year:  2002        PMID: 11987238     DOI: 10.1006/bcmd.2001.0480

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  8 in total

Review 1.  Gaucher disease: the metabolic defect, pathophysiology, phenotypes and natural history.

Authors:  Hagit N Baris; Ian J Cohen; Pramod K Mistry
Journal:  Pediatr Endocrinol Rev       Date:  2014-09

2.  Recent advances in the diagnosis and management of Gaucher disease.

Authors:  Sam E Gary; Emory Ryan; Alta M Steward; Ellen Sidransky
Journal:  Expert Rev Endocrinol Metab       Date:  2018-03-12

Review 3.  Gaucher disease: new developments in treatment and etiology.

Authors:  Ozgur Harmanci; Yusuf Bayraktar
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

4.  Case report of cholelithiasis in a patient with type 1 Gaucher disease.

Authors:  Afrim Avdaj; Naim Fanaj; Mirsade Osmani; Agron Bytyqi; Anila Cake
Journal:  Int J Surg Case Rep       Date:  2016-11-11

5.  Liver involvement in patients with Gaucher disease types I and III.

Authors:  Rodrigo Tzovenos Starosta; Filippo Pinto E Vairo; Alícia Dorneles Dornelles; Suélen Porto Basgalupp; Marina Siebert; Maria Lúcia Alves Pedroso; Carlos Thadeu Schmidt Cerski; Mário Reis Álvares-da-Silva; Ida Vanessa Doederlein Schwartz
Journal:  Mol Genet Metab Rep       Date:  2020-01-07

6.  High incidence of cholesterol gallstone disease in type 1 Gaucher disease: characterizing the biliary phenotype of type 1 Gaucher disease.

Authors:  Tamar H Taddei; James Dziura; Shu Chen; Ruhua Yang; Hideyuki Hyogo; Cameron Sullards; David E Cohen; Gregory Pastores; Pramod K Mistry
Journal:  J Inherit Metab Dis       Date:  2010-03-31       Impact factor: 4.982

Review 7.  Imiglucerase in the treatment of Gaucher disease: a history and perspective.

Authors:  Patrick B Deegan; Timothy M Cox
Journal:  Drug Des Devel Ther       Date:  2012-04-18       Impact factor: 4.162

Review 8.  Rethinking fatigue in Gaucher disease.

Authors:  Y Chen Zion; E Pappadopulos; M Wajnrajch; H Rosenbaum
Journal:  Orphanet J Rare Dis       Date:  2016-04-29       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.